Want to see TLRY full AI Analyst Report?
Tilray (TLRY) Stock Price & Analysis
TLRY Stock Chart & Stats
- Day’s Range
- $2.49 - $2.67
- 52-Week Range
- $2.49 - $15.70
- Previous Close
- $2.64
- Volume
- 3.69M
- Average Volume (3M)
- 4.27M
- Market Cap
- $373.90M
- Enterprise Value
- $743.22M
- Total Cash (Recent Filing)
- $218.01M
- Total Debt (Recent Filing)
- $371.93M
- Price to Earnings (P/E)
- ―
- Beta
- 1.17
- Next Earnings
- Jan 11, 2027 (Est.)
- EPS Estimate
- -0.16
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Diversified Global Platform
Tilray’s presence across cannabis, beverages, wellness, and pharmaceutical distribution creates multiple operating avenues and reduces reliance on one product category. Its international reach and broad portfolio can support cross-market growth and provide strategic flexibility as regulations and consumer demand evolve.
Beverage Growth And Profitability
Rapid beverage growth, improving gross margin, and BrewDog’s return to profitability indicate that operating actions are gaining traction in a meaningful segment. Better utilization, cost controls, and brand distribution can make beverage earnings a more durable contributor over the next several quarters.
Debt Reduction
Reducing outstanding principal lowers future financing obligations and can improve financial flexibility while the company works toward profitability. Debt repayment also complements Tilray’s manageable leverage profile, giving management more room to allocate capital toward growth and operational improvements.
Bears Say
Persistent Losses And Cash Burn
Ongoing negative operating and free cash flow shows that Tilray is not yet self-funding its operations, while continuing net losses weaken internal capital formation. Persistent cash burn can constrain investment, increase reliance on financing actions, and limit the durability of planned expansion.
Cannabis Revenue And Pricing Pressure
Cannabis remains a core business, yet lower revenue and international price compression are pressuring gross profit despite operational efficiency gains. If pricing weakness persists, Tilray may need to prioritize selected markets and profitable volume, limiting the segment’s near-term growth and earnings contribution.
Beer Market And Distribution Challenges
Distributor consolidation and a changing beer route to market can make shelf access, account coverage, and brand scaling more difficult. Tilray’s need to rationalize SKUs and focus distribution suggests ongoing execution work, which may restrain growth and require continued cost discipline.
Tilray News
TLRY FAQ
What was Tilray’s price range in the past 12 months?
What is Tilray’s market cap?
When is Tilray’s upcoming earnings report date?
How were Tilray’s earnings last quarter?
Is Tilray overvalued?
Does Tilray pay dividends?
What is Tilray’s EPS estimate?
How many shares outstanding does Tilray have?
What happened to Tilray’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Tilray?
What is the TipRanks Smart Score and how is it calculated?
Tilray Stock Smart Score
Company Description
Tilray
Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Irwin David Simon
- Employees
- 3,595
- Website
- www.tilray.com
- Address
- 265 Talbot Street West, Leamington, ON, N8H 5L4, CA
Tilray (TLRY) Earnings & Revenues
TLRY Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive. Tilray reported record revenue and gross profit, expanding consolidated and cannabis margins, strong international cannabis and BrewDog growth, U.S. craft beer brand momentum, debt reduction, and reaffirmed fiscal 2027 adjusted EBITDA guidance. These strengths were partly offset by a $40 million net loss, lower adjusted EBITDA, total cannabis revenue contraction, international price compression, Canadian adult-use headwinds, fuel costs, higher investment costs, and continued regulatory and market uncertainty.
View all TLRY earnings summariesTLRY Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |












